Literature DB >> 33683171

YY1-inudced activation of lncRNA DUXAP8 promotes proliferation and suppresses apoptosis of triple negative breast cancer cells through upregulating SAPCD2.

Zhen Yang1, Hongjian Ding1, Zhiyu Pan1, Huaqing Li1, Junbin Ding1, Qian Chen1.   

Abstract

Double homeobox A pseudogene 8 (DUXAP8) belongs to long non-coding RNAs (lncRNAs), which has been proven to promote the biological processes of multiple human cancers. Triple-negative breast cancer (TNBC) is the leading cause of cancer-related death in women worldwide. However, the specific role of lncRNA DUXAP8 and its underlying mechanism in TNBC remains to be unclear. We detected the expression of DUXAP8 in TNBC cells through qRT-PCR analysis. The effects of DUXAP8 silencing on TNBC cell proliferation and apoptosis were identified using CCK-8 assay, EdU assay, flow cytometry analysis and TUNEL assay. The downstream microRNA (miRNA) and messenger RNA (mRNA) of DUXAP8 were searched out through bioinformatics analysis and mechanism experiments. Rescue assays were conducted to verify the involvement of suppressor APC domain containing 2 (SAPCD2) in DUXAP8-mediated TNBC cell proliferation and apoptosis. DUXAP8 was highly expressed in TNBC cells compared to that in normal breast cells. Knockdown of DUXAP8 inhibited TNBC cell proliferation and accelerated cell apoptosis. DUXAP8 interacted with miR-29a-3p and thus enhanced the expression of SAPCD2. Moreover, YY1 transcription factor could bind to DUXAP8 promoter to activate the transcription of DUXAP8. YY1-induced transcriptional activation of DUXAP8 promotes TNBC cell growth through miR-29a-3p/SAPCD2 axis.

Entities:  

Keywords:  YY1; competing endogenous RNA (ceRNA); lncRNA DUXAP8; triple-negative breast cancer

Mesh:

Substances:

Year:  2021        PMID: 33683171      PMCID: PMC8043174          DOI: 10.1080/15384047.2021.1881201

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  41 in total

1.  SAPCD2 promotes invasiveness and migration ability of breast cancer cells via YAP/TAZ.

Authors:  Y Zhang; J-L Liu; J Wang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-04       Impact factor: 3.507

2.  lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6.

Authors:  Gabriel Eades; Benjamin Wolfson; Yongshu Zhang; Qinglin Li; Yuan Yao; Qun Zhou
Journal:  Mol Cancer Res       Date:  2014-09-24       Impact factor: 5.852

3.  lncRNAs HIF1A-AS2 facilitates the up-regulation of HIF-1α by sponging to miR-153-3p, whereby promoting angiogenesis in HUVECs in hypoxia.

Authors:  Lingjuan Li; Mingyue Wang; Zhujun Mei; Wenfeng Cao; Yun Yang; Yanmei Wang; An Wen
Journal:  Biomed Pharmacother       Date:  2017-10-04       Impact factor: 6.529

4.  A LncRNA-MAF:MAFB transcription factor network regulates epidermal differentiation.

Authors:  Vanessa Lopez-Pajares; Kun Qu; Jiajing Zhang; Dan E Webster; Brook C Barajas; Zurab Siprashvili; Brian J Zarnegar; Lisa D Boxer; Eon J Rios; Shiying Tao; Markus Kretz; Paul A Khavari
Journal:  Dev Cell       Date:  2015-03-23       Impact factor: 12.270

Review 5.  lncRNA/MicroRNA interactions in the vasculature.

Authors:  M D Ballantyne; R A McDonald; A H Baker
Journal:  Clin Pharmacol Ther       Date:  2016-03-31       Impact factor: 6.875

Review 6.  Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells.

Authors:  Xiaoqi Huo; Shuanglin Han; Guang Wu; Olivier Latchoumanin; Gang Zhou; Lionel Hebbard; Jacob George; Liang Qiao
Journal:  Mol Cancer       Date:  2017-10-23       Impact factor: 27.401

7.  A regulated PNUTS mRNA to lncRNA splice switch mediates EMT and tumour progression.

Authors:  Simon Grelet; Laura A Link; Breege Howley; Clémence Obellianne; Viswanathan Palanisamy; Vamsi K Gangaraju; J Alan Diehl; Philip H Howe
Journal:  Nat Cell Biol       Date:  2017-08-21       Impact factor: 28.824

8.  Long noncoding RNA PXN-AS1-L promotes the malignancy of nasopharyngeal carcinoma cells via upregulation of SAPCD2.

Authors:  Xiaodong Jia; Po Niu; Cuncun Xie; Hongjian Liu
Journal:  Cancer Med       Date:  2019-06-07       Impact factor: 4.452

9.  miR‑29a‑3p represses proliferation and metastasis of gastric cancer cells via attenuating HAS3 levels.

Authors:  Feihu Bai; Mengna Jiu; Yanjie You; Yaning Feng; Ruijuan Xin; Xiaogang Liu; Lirong Mo; Yongzhan Nie
Journal:  Mol Med Rep       Date:  2018-04-19       Impact factor: 2.952

10.  LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p.

Authors:  Xiaotian Luan; Yankui Wang
Journal:  J Gynecol Oncol       Date:  2018-11       Impact factor: 4.401

View more
  7 in total

Review 1.  Functions of lncRNA DUXAP8 in non-small cell lung cancer.

Authors:  Cui Wu; Wu Song; Zhongnan Wang; Bingmei Wang
Journal:  Mol Biol Rep       Date:  2022-01-15       Impact factor: 2.316

2.  YY1 as a promoter regulating the circ_0001946/miR-671-5p/EGFR axis to promote chemotherapy resistance in breast cancer cells.

Authors:  Ge Gao; Xiaoyan Li; Jiabeini Zhang; Hong Yu
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

Review 3.  Epigenetic Changes and Functions in Pneumoconiosis.

Authors:  Yiping Li; Zhiwei Cheng; Hui Fan; Changfu Hao; Wu Yao
Journal:  Oxid Med Cell Longev       Date:  2022-01-20       Impact factor: 6.543

4.  LINC01224 promotes colorectal cancer progression through targeting miR-485-5p/MYO6 axis.

Authors:  Jingfeng Gu; Liang Dong; Yun Wang; Wenjia Nie; Wencong Liu; Ji-An Zhao
Journal:  World J Surg Oncol       Date:  2021-09-17       Impact factor: 2.754

5.  The double homeobox a pseudogene 8 accelerates cell proliferation, migration, and invasion in colon cancer.

Authors:  Shengxun Mao; Zhaohong Mo; Runxin Wu; Bin Lai; Zhiyong Zhou; Yi Song; Xi Ouyang; Xingen Zhu
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

6.  LncRNA DUXAP8 as a prognostic biomarker for various cancers: A meta-analysis and bioinformatics analysis.

Authors:  Yongfeng Wang; Xianglai Jiang; Dongzhi Zhang; Yuanbin Zhao; Xiaoyong Han; Lihui Zhu; Jingyao Ren; Yubin Liu; Jiarong You; Haolan Wang; Hui Cai
Journal:  Front Genet       Date:  2022-08-15       Impact factor: 4.772

7.  Specificity protein 1-induced serine peptidase inhibitor, Kunitz Type 1 antisense RNA1 regulates colorectal cancer cell proliferation, migration, invasion and apoptosis through targeting heparin binding growth factor via sponging microRNA-214.

Authors:  Ying Fang; Qianqian Yang
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.